Biomarcadores y Abordaje Personalizado del Cáncer (BioPAC)
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Martinelli P, Carrillo-de Santa Pau E, Cox T, Sainz B, Dusetti N, Greenhalf W, Rinaldi L, Costello E, Ghaneh P, Malats N, Büchler M, Pajic M, Biankin AV, Iovanna J, Neoptolemos J, Real FX.
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer.
Gut . : .
-
Villacampa A, Shamoon L, Valencia I, Morales C, Figueiras S, de la Cuesta F, Sánchez-Niño D, Díaz-Araya G, Sánchez-Pérez I, Lorenzo Ó, Sánchez-Ferrer CF, Peiró C.
SARS-CoV-2 S Protein Reduces Cytoprotective Defenses and Promotes Human Endothelial Cell Senescence.
AGING AND DISEASE . : .
-
Guerrero P, Albarrán V, González-Merino C, García de Quevedo C, Sotoca P, Chamorro J, Rosero DI, Barrill A, Alía V, Calvo JC, Moreno J, Pérez de Aguado P, Álvarez-Ballesteros P, San Román M, Serrano JJ, Soria A, Olmedo ME, Saavedra C, Cortés A, Gómez A, Lage Y, Ruiz Á, Ferreiro MR, Longo F, Guerra E, Martínez-Delfrade Í, Garrido P, Gajate P.
Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.
ONCOLOGIST . : .
-
Biesma NC, Graus MUJE, Cirkel GA, Besselink MG, de Groot JWB, Koerkamp BG, Herbschleb KH, Los M, Verdonk RC, Wilmink JW, Cervantes A, Valle JW, Valkenburg-van Iersel LBJ, Froeling FEM, Molenaar IQ, Daamen LA, de Vos-Geelen J, van Santvoort HC.
Perspectives of the medical oncologist regarding adjuvant chemotherapy for pancreatic cancer: An international expert survey and case vignette study.
EJSO . 51(3): 109544-109544.
-
Xue N, Sabroso-Lasa S, Merino X, Munzo-Beltran M, Schuurmans M, Olano M, Estudillo L, Ledesma-Carbayo MJ, Liu J, Fan R, Hermans JJ, van Eijck C, Malats N.
A fusion-based deep-learning algorithm predicts PDAC metastasis based on primary tumour CT images: a multinational study.
Gut . : .
-
López-López C, de Castro EM, Montes AF, Orozco EJ, Peraita SL, Vera R, Cerdá P, Calvo M, Paredes BG, de Mena ML, La Casta A, Gallego J, Adeva J, Cano JMC, Ruiz-Casado A, Vidal-Tocino R, García-García T, Pazo-Cid R, Garrote MR, Sastre J.
Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry.
CLINICAL & TRANSLATIONAL ONCOLOGY . : .
-
Panaitescu-Damian A, Gürcinar I, Stoica V, Paiella S, Hollenbach M, Regel I, Swibold D, Capurso G, Carrato A, Michl P, Arnes L.
Addressing Pancreatic Exocrine Insufficiency and the Impact of Pancreatic Enzyme Replacement Therapy Shortages in Europe.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL . : .
-
Urbanova M, Viol F, Ruiz-Cañas L, Koniaris E, Saksis R, Batres-Ramos S, Earl J, Kataki A, Buocikova V, Burikova M, Cihova M, Rojikova L, Makovicky P, Matuskova M, Kohl Y, Riedmayer A, Makova M, Baciak L, Gogola D, Rogoza O, Rovite V, Sainz B Jr, Smolkova B, Schrader J.
Aurora kinase A inhibition as a synthetic lethality strategy in ARID1A-mutated gastroenteropancreatic neuroendocrine carcinoma.
CANCER LETTERS . 634: 218033-218033.
-
Bakirdögen D, Görgülü K, Xin J, Richter L, Alcalá S, Ruiz-Cañas L, Dai C, Frank KJ, Wu N, Diakopoulos KN, Ozturk H, Demircioglu D, Peschke K, Ranjan R, Fusco F, Martinez-Useros J, Fernandez-Aceñero MJ, Chhabra NF, López-Gil JC, Ai J, Ruess DA, Kaya-Aksoy E, Schmidt F, Kohlmann L, Berninger A, Yangin H, Schicktanz F, Steiger K, Demir IE, Schmid RM, Reichert M, Adli M, Lesina M, Sainz B Jr, Algül H.
c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT.
MOLECULAR CANCER . : .